Virtu Financial LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1533964 New York, NY

Position in VRTX

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$3,408,886

+$2,732,020 QoQ

Shares Held

7,634

+411.3% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.28%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Virtu Financial LLC holds $48,923,071 across 139 Biotechnology names. VRTX ranks #2 (7.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TERN	Terns Pharmaceuticals, Inc.	70,715	$3,728,094
2	VRTX	Vertex Pharmaceuticals Inc / Ma This page	7,634	$3,408,886
3	CNTA	Centessa Pharmaceuticals plc	67,775	$2,692,023
4	APLS	Apellis Pharmaceuticals, Inc.	54,785	$2,204,000
5	BMRN	Biomarin Pharmaceutical Inc	38,479	$2,173,678
6	IBRX	ImmunityBio, Inc.	262,298	$2,011,825
7	ANAB	Anaptysbio, Inc	33,323	$1,848,093
8	ABVX	Abivax S.A.	9,551	$1,063,503

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,408,886	7,634	+411.3%	Shares	Defined	2026-05-14
2025-12-31	$676,866	1,493	-83.5%	Shares	Defined	2026-02-23
2025-03-31	$4,394,408	9,064	+20.5%	Shares	Defined	2025-05-12
2024-12-31	$3,028,706	7,521	+60.6%	Shares	Defined	2025-02-11
2024-09-30	$2,177,504	4,682	-67.5%	Shares	Defined	2024-11-20
2024-06-30	$6,743,474	14,387	+121.8%	Shares	Defined	2024-08-09
2022-12-31	$1,873,027	6,486	-5.8%	Shares	Defined	2023-02-15
2021-09-30	$1,249,232	6,887	+555.9%	Shares	Defined	2021-11-12
2020-06-30	$304,825	1,050	—	Shares	Defined	2020-08-07
No filing history on record for this holder in this stock.